Page last updated: 2024-09-03

imatinib mesylate and Papilledema

imatinib mesylate has been researched along with Papilledema in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, RA; Irshad, FA1
DeLuca, C; Haskes, C; Shenouda-Awad, N; Wrzesinski, S1
Arakawa, A; Kami, M; Kato, D; Kishi, Y; Kusumi, E; Miyakoshi, S; Morinaga, S; Murashige, N; Muto, Y; Taniguchi, S; Ueyama, J; Yuji, K1

Other Studies

3 other study(ies) available for imatinib mesylate and Papilledema

ArticleYear
Bartonella henselae neuroretinitis in a 15-year-old girl with chronic myelogenous leukemia.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2009, Volume: 13, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Antibodies, Bacterial; Antineoplastic Agents; Bartonella henselae; Benzamides; Cat-Scratch Disease; Doxycycline; Eye Infections, Bacterial; Female; Fluorescein Angiography; Humans; Imatinib Mesylate; Immunoglobulin G; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macular Edema; Magnetic Resonance Imaging; Papilledema; Piperazines; Pyrimidines; Retinitis; Tomography, Optical Coherence

2009
Imatinib mesylate (Gleevec) induced unilateral optic disc edema.
    Optometry and vision science : official publication of the American Academy of Optometry, 2012, Volume: 89, Issue:10

    Topics: Aged; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Optic Disk; Papilledema; Piperazines; Protein-Tyrosine Kinases; Pyrimidines

2012
Visual disturbance due to retinal edema as a complication of imatinib.
    Leukemia, 2004, Volume: 18, Issue:6

    Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Papilledema; Piperazines; Pyrimidines; Vision Disorders

2004